Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida.
Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, Florida.
JAMA Netw Open. 2021 Jan 4;4(1):e2032276. doi: 10.1001/jamanetworkopen.2020.32276.
It has been established that disparities in race and socioeconomic status are associated with outcomes of non-small cell lung cancer. However, it remains unknown whether this extends to stage I, II, or III small cell lung cancer (SCLC), or limited-stage SCLC (L-SCLC).
To investigate the associations of race, socioeconomic factors, and treatment characteristics with survival among patients with L-SCLC.
DESIGN, SETTING, AND PARTICIPANTS: Demographic information for patients with L-SCLC diagnosed between 2004 and 2014 was obtained from the National Cancer Database. The follow-up end point is death or last follow-up (date of last contact). Patients were divided into 5 mutually exclusive cohorts by race. Data analysis was performed in October 2019.
Cox proportional hazards models were used to calculate univariable and multivariable models. Multivariable analyses were conducted to assess the associations of race and socioeconomic factors with risk-adjusted outcomes. Overall survival between groups was depicted by Kaplan-Meier curves.
Of 72 409 patients analyzed (median [range] age, 67.0 [23.0-90.0] years), 40 289 (55.6%) were women. The distribution of disease stage was 10 619 patients (14.7%) with stage I disease, 7689 patients (10.6%) with stage II disease, and 54 101 patients (74.7%) with stage III disease. The median (range) duration of follow-up was 8.2 (2.4-15.8) months. Compared with White patients, the hazard of death decreased to 0.92 (95% CI, 0.89-0.95; P < .001) for African American patients and 0.83 (95% CI, 0.77-0.91; P < .001) for Asian patients. The difference in median survival among different racial groups was significant only among those with stage III SCLC. Other factors associated with better survival were female sex, high income, high education, private insurance, diagnostic confirmation by positive cytological analysis, increase in number of sampled regional lymph nodes, and earlier stage at diagnosis.
This analysis highlights disparities in race and socioeconomic factors associated with outcomes of L-SCLC. Racial minorities, including African American and Asian patients, have better survival than White patients for L-SCLC after adjustment for sociodemographic factors.
已经确定,种族和社会经济地位的差异与非小细胞肺癌的预后相关。然而,目前尚不清楚这种差异是否会扩展到局限期小细胞肺癌(L-SCLC)或广泛期小细胞肺癌(L-SCLC)。
调查种族、社会经济因素和治疗特征与 L-SCLC 患者生存的关联。
设计、地点和参与者:从国家癌症数据库获取了 2004 年至 2014 年间诊断为 L-SCLC 的患者的人口统计学信息。随访终点为死亡或最后一次随访(最后一次联系日期)。患者根据种族分为 5 个互斥队列。数据分析于 2019 年 10 月进行。
使用 Cox 比例风险模型计算单变量和多变量模型。进行多变量分析以评估种族和社会经济因素与风险调整结局的关联。通过 Kaplan-Meier 曲线描绘组间总生存情况。
在分析的 72409 例患者中(中位[范围]年龄,67.0[23.0-90.0]岁),40289 例(55.6%)为女性。疾病分期分布为 10619 例(14.7%)为 I 期疾病,7689 例(10.6%)为 II 期疾病,54101 例(74.7%)为 III 期疾病。中位(范围)随访时间为 8.2(2.4-15.8)个月。与白人患者相比,非裔美国患者的死亡风险降低至 0.92(95%CI,0.89-0.95;P<0.001),亚洲患者降低至 0.83(95%CI,0.77-0.91;P<0.001)。不同种族组之间的中位生存差异仅在 III 期 SCLC 患者中显著。其他与生存较好相关的因素包括女性、高收入、高教育程度、私人保险、通过阳性细胞学分析确诊、采样区域淋巴结数量增加以及诊断时分期较早。
本分析强调了与 L-SCLC 结局相关的种族和社会经济因素的差异。在调整社会人口因素后,少数族裔,包括非裔美国人和亚洲患者,在 L-SCLC 中的生存情况要好于白人患者。